EKM Scientific
Advisory Board Members
|
Thomas D.Y. Chung, Ph.D. - |
Thomas is the Chair of the Scientific Advisory Board. Chung, who focuses on the knowledge management and electronic laboratory notebook areas, is also an independent consultant and specializes in assisting fast growth life sciences companies and major pharmaceutical companies in strategies for the development, implementation and integration of novel technologies in the drug discovery area, and in making critical assessments as to whether these technologies are likely to be successfully commercialized and demonstrate the required return-on-investment. He has experience in a broad range of life sciences specialties including the pharmaceutical, biotechnology and medical device areas. Chung brings more than 18 years of experience as a scientist and R&D executive with four major pharmaceutical companies – including DuPont Pharmaceutical Co. and Bristol-Myers Squibb – and a successful venture-backed life sciences company. At DuPont, he built, managed and strategically positioned a world-class lead discovery operation that was responsible for early drug discovery. He had a leadership role in evaluating novel technologies for acquisition by DuPont and in designing and implementing development strategies following their acquisition. Chung has a Bachelor’s of
Science degree in chemistry from MIT, and a Ph.D. in bio-inorganic chemistry
from the |
|
|
|
|
Chris Coppin M.D., Ph.D. -
Senior Research Manager, Medtronic Heart Valves |
Chris Coppin grew up in
|
|
|
|
|
EF Consulting, President |
Roger
Fraumann is an information technology and business
development professional with over 25 years of experience in global business
development, strategic marketing and sales. His expertise includes worldwide
partner, supplier and sales channel development, contract negotiations and
business intelligence. A frequent advisor and speaker, he is often asked to
discretely resolve intractable business development challenges. In 1989, he co-founded EFConsulting
(EFC) to provide personalized marketing and business development services for
select clients. Roger frequently draws on his extensive experience and
contacts across the computer, networking and high technology industries to
provide targeted research and initial business overtures. Clients often
consult with Roger for highly creative and results-oriented problem solving.
His strong inter-personal skills contribute to rapidly building strong
alliances and teams. Roger has held
various management positions in organizations and was most recently
affiliated with IBM where he lead business
development efforts across |
|
President and Co-Founder, PaxVax,
Inc. |
Daniel has an extensive scientific
and medical background, as well as seasoned experience in raising capital in
today’s competitive tech market. Henderson, former president and CEO of
San Diego-based Arizeke Pharmaceuticals, has helped
raise more than $40 million for two life science companies, Calydon, Inc. and Microgenics
Corp. He sold Microgenics in 1992 diagnostics giant
Boehringer-Mannheim for $60 million. Boehringer-Mannheim is now part of
pharmaceutical leader Roche. Henderson – who invented the ARCA family
of anti-cancer therapeutics while at |
|
Jay Kunin, Ph.D. - |
Jay is a pharmaceutical and medical information
technology consultant, and an expert in regulatory compliance of IT systems.
Kunin, who began his tech career in software research at |
|
Gerry Martin - Vice
President, Corporate Licensing and Technology Alliances, Retired
Abbott Laboratories |
Gerry, a life sciences consultant, has more than three
decades of life sciences and business leadership under his belt. Martin is a
member of the founding committee of the Life Sciences Information Technology
(LSIT) Global Institute, a San Diego-based nonprofit launched to facilitate
collaborations that create open source LSIT architectures that enable Good
Informatics Practices and accelerate improvements in global public health.
Martin spent 30 years at Abbott Laboratories, where he was Vice President,
Corporate Licensing and Technology Alliances. He and his team were
responsible for planning and executing multi-divisional business strategies,
including in/out licensing and global alliances on a global basis for
Abbott's various divisions. Martin began his career at Abbott in 1970 in
sales. In 1980, he became director of Abbott’s operations in the |
|
Associate Professor of Informatics Laboratory Informatics Graduate Program |
Mahesh is an associate
professor for Before heading to |